McGuireWoods is expanding its patent litigation capabilities with the
addition of New York partners Benjamin Hsing,
Wanda French-Brown and
Irene Hudson, who bring a wealth of patent litigation experience for life sciences
Hsing, French-Brown and Hudson represent pharmaceutical companies in patent
matters involving Hatch-Waxman Abbreviated New Drug Applications (ANDA).
They also advise technology, biotechnology and medical device companies.
All three join McGuireWoods from BakerHostetler.
“Ben, Wanda and Irene are highly respected for devising strategies to help
domestic and international companies navigate complex patent litigation
David Finkelson, chair of the firm’s Intellectual Property & Patent Litigation
“Their skill in ANDA-based litigation, in particular, will be an important
asset for our healthcare and life sciences clients,” added
Holly Buckley, co-leader of the firm’s healthcare and life sciences industry team.
A former patent examiner, Hsing has tried numerous high-profile cases on
behalf of major pharmaceutical and technology companies and has conducted
intellectual property due diligence investigations for acquisitions and
licensing deals. LMG Life Sciences named Hsing New York’s 2017 Patent
Strategy Management Attorney of the Year and Chambers USA has ranked him
for intellectual property each year since 2013.
French-Brown has represented life sciences industry companies in patent
litigation cases involving pharmaceuticals (Hatch-Waxman), healthcare
diagnostics, medical devices, food chemistry and biotechnology.
French-Brown’s background includes a decade as a registered pharmacist. She
advises clients on Food and Drug Administration guidelines governing the
entry of generic and biosimilar pharmaceutical products. She also counsels
pharmaceutical clients on the scope and coverage of new patents, new drug
product exclusivity and litigation strategy.
Hudson advises Fortune 500 companies, large corporations and emerging
pharmaceutical companies and has significant experience coordinating
multijurisdictional litigation. She represents clients in multipatent and
multidefendant cases domestically and internationally, manages worldwide
trademark portfolios and handles trademark and trade dress infringement
“We’re delighted to welcome Ben, Wanda and Irene,” said
Noreen Kelly, managing partner of the firm’s New York office. “They enhance our client
service capabilities nationally and continue our growth in New York.”
McGuireWoods’ healthcare and life sciences industry team delivers
integrated services to companies that develop, manufacture and distribute
pharmaceuticals, medical devices and biological products. In intellectual
property matters, the firm’s coordinated team of trial and transactional
lawyers handle bet-the-company litigation, counseling, competitor patent
monitoring, licensing and patent prosecution. The firm earned a “standout”
rating for IP litigation in the 2019 edition of BTI Litigation Outlook based on feedback from corporate counsel.